Preventative health
Report
The Australian ‘drug budget’: government drug policy expenditure 2021/22
This report provides an estimate of Australian governments’ proactive expenditure on illicit drugs for the financial year 2021/22. Four drug policy domains were included: prevention, treatment, harm reduction, and law enforcement. The report finds that Australian governments spend more on law enforcement in illicit drug policy than treatment, prevention and harm reduction combined.
Report
Equity, accessibility and appropriate delivery of outpatient and community mental health care in New South Wales
This report brings together priorities identified in seven reviews conducted at state and national level over the last four years, with eleven simultaneously underway at present. The recommendations focus on early intervention within the community, as well as improved integration and navigation, reducing the burden on public emergency and crisis care and ultimately providing better...
Research Summary
Do more Better Access sessions for men with depression or anxiety lead to improvements? A target trial emulation study
The Better Access initiative provides Medicare rebates to eligible people (those with a diagnosed mental disorder) so that they can access the formal mental health support services they need. This research summary outlines the evidence base on the effectiveness of the Better Access policy in addressing mental ill-health among Australian men before, during and after...
Research Summary
Associations between vaping, mental health and risky health behaviours over time in Australian men
Vaping is a significant public health concern, due to its association with other risky health behaviours. This research summary highlights that men who engage in risky behaviours (illicit drug use, heavy drinking, gambling or smoking) are more likely to engage in vaping. Interventions that successfully reduce these risky behaviours may also reduce vaping.
Report
Preventable burden of mito: final report
The Mito Foundation commissioned the Centre for International Economics to provide this economic evidence about the preventable burden of mitochondrial (mito) disease in Australia to help understand the greatest challenges faced by people with mito, and the opportunities to intervene to make peoples’ lives better.